Latest News

FDA approves Blueprint Medicines’ precision therapy for rare form of gastrointestinal cancer

Text FDA Approved appearing behind ripped brown paper.

The agency on Thursday approved Ayvakit (avapritinib) for gastrointestinal stromal tumor, or GIST, that harbors a PDGFRa exon 18 mutation. Still, identifying patients could be the biggest challenge, an analyst wrote.

Source link

Related posts

Medical News Today: Repairing leaky blood-brain barrier may rejuvenate brain function


Evaluate Ltd. revolutioniert mit der Einführung von Product Specific PTRS die Risikobewertung bei Forschung und Entwicklung in der Pharmaindustrie


7 Effective Ways To Improve Your Mental Health


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World